NCT05444088View on ClinicalTrials.gov

Study of SHR-8068 Combined With Adebrelimab and Bevacizumab in the Treatment of Advanced Hepatocellular Carcinoma

PHASE1/PHASE2RecruitingINTERVENTIONAL
Enrollment

129

Participants

Timeline

Start Date

August 2, 2022

Primary Completion Date

June 30, 2026

Study Completion Date

June 30, 2026

Conditions
Advanced Hepatocellular Carcinoma
Interventions
DRUG

Adebrelimab

intravenous infusion

DRUG

Bevacizumab

intravenous infusion

DRUG

SHR-8068

intravenous infusion

Trial Locations (1)

230000

RECRUITING

Anhui Provincial Hospital Ethics Commitee, Hefei

All Listed Sponsors
lead

Suzhou Suncadia Biopharmaceuticals Co., Ltd.

INDUSTRY